Brain health assessment technology developed at McMaster gives the brain ‘a voice’
This article was first published on Brighter World. Read the original article. A trailblazing brain health assessment technology developed at McMaster is...
VoxNeuro Closes $4 Millon to Help Diagnose Concussions and Alzheimer’s Disease
Original Press Release from Betakit Backed by decades of research, VoxNeuro aims to bring objectivity to brain health assessments. Cognitive...
VoxNeuro Announces Collaboration with the Canadian Armed Forces and Launch of Clinical Study Measuring Impact of Training-Related Sub-Concussive Exposure
VoxNeuro and CAF have partnered to study the cognitive effects following intense military training regimens designed to reflect a combat...
VoxNeuro Announces Collaboration with Boston University and Launch of Clinical Studies Focusing on Concussion and Alzheimer’s Disease
ORIGINAL PRESS RELEASE, Douglas Martin, AP News, September 7, 2022 VoxNeuro Inc. (“VoxNeuro” or the “Company”), a commercial-stage Software-as-a-Medical-Device (SaMD)...
VoxNeuro Announces Significant Milestones on its Mission to Become “The Brain Company”
The Forge client VoxNeuro Inc. has met three significant developments recently. The Software as a Medical Device (SaMD) brain health...
VoxNeuro revolutionizing brain health
VoxNeuro, a Hamilton-based neuroscience and health tech company, has been featured on Canadian Healthcare Technology for its groundbreaking approach to...
VoxNeuro’s tech rolled out to two clinics
VoxNeuro The Forge alumnus was featured in The Hamilton Spectator article. Read the ORIGINAL ARTICLE, Saira Peesker, The Hamilton Spectator,...
VoxNeuro secures Class II Medical Device designation
On July 28, 2021, VoxNeuro, The Forge alumnus, received Health Canada Class II Medical Device designation for its proprietary Cognitive...
VoxNeuro releases software as a medical device in the United States
VoxNeuro, The Forge alumnus, has announced the release of their software as a medical device, the Cognitive Health Assessment Management...
VoxNeuro featured on CBC’s Marketplace
On January 26, 2021, VoxNeuro’s breakthrough neurotechnology was covered on CBC’s Marketplace. The feature highlighted Susie Goulding, founder of COVID...
Bay Area Health Trust Invests in VoxNeuro
Bay Area Health Trust announced their investment in VoxNeuro’s latest funding round to support The Forge alumnus’ national expansion. VoxNeuro...
VoxNeuro Collaborates With The Canadian Football League Alumni Association
The Forge client VoxNeuro and the Canadian Football League Alumni Association (CFLAA) signed a collaboration agreement. The two organizations are...
VoxNeuro and UHN to Launch Concussion Study
VoxNeuro, an alumnus of The Forge, has signed an agreement with The Kite Research Institute (KITE) to complete a multi-month...
VoxNeuro Addressing Consequences of COVID-19
The Forge alumnus VoxNeuro is a Hamilton-based startup commercializing McMaster technology and research. VoxNeuro has been able to pivot and...